Are pharmaceutical drug prices too high in the EU?


A recent publication from the WHO identifies that EU pharmaceutical drug prices are too high and that the process pharmaceutical companies use to determine price is too opaque.

Stay in the know, subscribe to our newsletter

Be the first to receive exclusive content on the latest from the pharmaceutical and market access sector.